The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine ...

The reformulated vaccine defends against new omicron strains, including XBB omicron variants. The panel stopped short of ...

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here's what we know.

A panel of experts on Thursday agreed that the bivalent COVID-19 vaccines should be used as both initial and booster shots, ...

It's part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

"Bivalent is better. Simple is better," one advisory committee member said. The final decision to greenlight adapted COVID-19 shots in the future is up to the FDA and CDC. Three more takeaways from ...

A panel of independent experts that advises the Food and Drug Administration on vaccines has backed a proposal to use the ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...